BioGlyph offers a format-agnostic platform that provides scientists with intuitive design tools, agnostic registration, and advanced data labeling for biologics research and development. This solution addresses the complexity of managing diverse protein classes and enhances molecular fitness through in-silico simulations.
Funding
Funding not disclosed
Founders
Product
Problem
Biologics research and development involves managing diverse protein classes and complex data, which can be challenging for scientists. Existing tools often lack intuitive design features, format-agnostic registration, and advanced data labeling capabilities, hindering molecular fitness optimization.
Solution
BioGlyph offers a format-agnostic platform designed to streamline biologics research and development. The platform provides scientists with intuitive design tools, agnostic registration, and advanced data labeling features, all within a single interface. By supporting standard markup languages and offering in-silico simulations, BioGlyph enhances molecular fitness and simplifies the management of diverse protein classes. This enables scientists to push the boundaries of what is possible in biologics research.
Target Audience
The primary users are scientists involved in biologics research and development, including protein engineers and biologics experts.
Features
- Intuitive drag-and-drop interface for easy design and manipulation of biologics.
- Support for standard markup languages, including Antibody Markup Language (AbML) and Verified Taxonomy for Antibodies (VERITAS).
- Comprehensive building blocks encompassing every possible protein class.
- AI platform for in-silico simulations to optimize molecular fitness.